title: The incidence, prevalence, and severity of sarcoidosis in New York City firefighters.
abstract: OBJECTIVE
  The etiology of sarcoidosis is unknown, but epidemiology suggests that environmental agents are a factor. Because firefighters are exposed to numerous toxins, we questioned whether sarcoidosis was increased in this cohort.
  
  
  METHODS
  The New York City Fire Department (FDNY), employing > 11,000 firefighters and nearly 3,000 emergency medical services (EMS) health-care workers (HCWs).
  
  
  METHODS
  In 1985, FDNY initiated a surveillance program to determine the incidence, prevalence, and severity of biopsy-proven sarcoidosis in firefighters. In 1995, EMS HCWs were added as control subjects.
  
  
  RESULTS
  Between 1985 and 1998, 4 prior cases and 21 new cases of sarcoidosis were found in FDNY firefighters. Annual incidence proportions ranged from 0 to 43.6/100,000, and averaged 12.9/100,000. On July 1, 1998, the point prevalence was 222/100,000. For EMS HCWs, annual incidence proportions were zero. Radiographic stage 0 or stage 1 sarcoidosis was found in 19 firefighters (76%), and stage 3 was found in 1 firefighter (4%). Pulmonary function (FVC, FEV(1), and diffusing capacity for carbon monoxide) was normal in 17 firefighters (68%), and reduced to </= 65% predicted in 2 firefighters (8%). Maximum oxygen consumption (MVO(2)) was normal in 10 of 17 firefighters (59%), and reduced to 65% predicted in 3 firefighters (12%). Five of seven firefighters (71%) with abnormal MVO(2) had gas exchange abnormalities, and none had O(2) desaturation. All returned to fire fighting.
  
  
  CONCLUSIONS
  Annual incidence proportions and point prevalence were increased in FDNY firefighters as compared to EMS HCWs and historical controls. Radiographs and physiologic measurements demonstrated only minimal impairment.
authors.affiliation: New York City Fire Department, Bureau of Health Services, Bronx, NY, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Prezant
authors.forename: A
authors.initials: A
authors.lastname: Dhala
authors.forename: A
authors.initials: A
authors.lastname: Goldstein
authors.forename: D
authors.initials: D
authors.lastname: Janus
authors.forename: F
authors.initials: F
authors.lastname: Ortiz
authors.forename: T K
authors.initials: TK
authors.lastname: Aldrich
authors.forename: K J
authors.initials: KJ
authors.lastname: Kelly
mesh_terms: D000328:Adult; D001706:Biopsy; D005080:Exercise Test; D005260:Female; D005390:Fires; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009519:New York City / Q000453:epidemiology; D009784:Occupational Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D016273:Occupational Exposure / Q000009:adverse effects; D015995:Prevalence; D013902:Radiography, Thoracic; D012124:Respiratory Care Units / Q000706:statistics & numerical data; D012129:Respiratory Function Tests; D012189:Retrospective Studies; D017565:Sarcoidosis, Pulmonary / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D012720:Severity of Illness Index; D014505:Urban Population